Cargando…

Korean medicines for poor ovarian reserve in infertility: A protocol for a multicenter observational study

INTRODUCTION: Many infertile patients have used Korean medicines (KMs) as a primary or adjuvant therapeutic method to improve in vitro fertilization success rates. The aim of this multicenter observational study is to investigate the effects of KMs on poor ovarian reserve (POR) in infertile patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Tae-Young, Jun, Ji Hee, Lee, Hye Won, Ang, Lin, Kim, Eun Seop, Go, Ho Yeon, You, Sooseong, Lee, Myeong Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946327/
https://www.ncbi.nlm.nih.gov/pubmed/31689817
http://dx.doi.org/10.1097/MD.0000000000017731
_version_ 1783485339721007104
author Choi, Tae-Young
Jun, Ji Hee
Lee, Hye Won
Ang, Lin
Kim, Eun Seop
Go, Ho Yeon
You, Sooseong
Lee, Myeong Soo
author_facet Choi, Tae-Young
Jun, Ji Hee
Lee, Hye Won
Ang, Lin
Kim, Eun Seop
Go, Ho Yeon
You, Sooseong
Lee, Myeong Soo
author_sort Choi, Tae-Young
collection PubMed
description INTRODUCTION: Many infertile patients have used Korean medicines (KMs) as a primary or adjuvant therapeutic method to improve in vitro fertilization success rates. The aim of this multicenter observational study is to investigate the effects of KMs on poor ovarian reserve (POR) in infertile patients. METHODS AND ANALYSIS: We will perform a prospective multicenter observational study. This study will recruit 50 women between 25 and 44 years of age with infertility caused by POR from among patients who visit the KM clinic. All participants will visit the KM clinic on the 2nd or 3rd day of menstruation to receive the KMs. KM treatment will be delivered for 3 menstrual cycles (3 months) and will include herbal decoction, acupuncture, or moxibustion on demand. Every participant will be assessed based on KM clinical symptoms, a quality of life questionnaire, and ovarian reserve test results. ETHICS AND DISSEMINATION: The study was approved by Institutional Review Board of Semyung University (SMU-IM-190501). The results will be published in a peer-reviewed journal and will be disseminated electronically and in print. TRIAL REGISTRATION NUMBER: Clinical Research Information Service: KCT0004209.
format Online
Article
Text
id pubmed-6946327
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-69463272020-01-31 Korean medicines for poor ovarian reserve in infertility: A protocol for a multicenter observational study Choi, Tae-Young Jun, Ji Hee Lee, Hye Won Ang, Lin Kim, Eun Seop Go, Ho Yeon You, Sooseong Lee, Myeong Soo Medicine (Baltimore) 3800 INTRODUCTION: Many infertile patients have used Korean medicines (KMs) as a primary or adjuvant therapeutic method to improve in vitro fertilization success rates. The aim of this multicenter observational study is to investigate the effects of KMs on poor ovarian reserve (POR) in infertile patients. METHODS AND ANALYSIS: We will perform a prospective multicenter observational study. This study will recruit 50 women between 25 and 44 years of age with infertility caused by POR from among patients who visit the KM clinic. All participants will visit the KM clinic on the 2nd or 3rd day of menstruation to receive the KMs. KM treatment will be delivered for 3 menstrual cycles (3 months) and will include herbal decoction, acupuncture, or moxibustion on demand. Every participant will be assessed based on KM clinical symptoms, a quality of life questionnaire, and ovarian reserve test results. ETHICS AND DISSEMINATION: The study was approved by Institutional Review Board of Semyung University (SMU-IM-190501). The results will be published in a peer-reviewed journal and will be disseminated electronically and in print. TRIAL REGISTRATION NUMBER: Clinical Research Information Service: KCT0004209. Wolters Kluwer Health 2019-11-01 /pmc/articles/PMC6946327/ /pubmed/31689817 http://dx.doi.org/10.1097/MD.0000000000017731 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 3800
Choi, Tae-Young
Jun, Ji Hee
Lee, Hye Won
Ang, Lin
Kim, Eun Seop
Go, Ho Yeon
You, Sooseong
Lee, Myeong Soo
Korean medicines for poor ovarian reserve in infertility: A protocol for a multicenter observational study
title Korean medicines for poor ovarian reserve in infertility: A protocol for a multicenter observational study
title_full Korean medicines for poor ovarian reserve in infertility: A protocol for a multicenter observational study
title_fullStr Korean medicines for poor ovarian reserve in infertility: A protocol for a multicenter observational study
title_full_unstemmed Korean medicines for poor ovarian reserve in infertility: A protocol for a multicenter observational study
title_short Korean medicines for poor ovarian reserve in infertility: A protocol for a multicenter observational study
title_sort korean medicines for poor ovarian reserve in infertility: a protocol for a multicenter observational study
topic 3800
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946327/
https://www.ncbi.nlm.nih.gov/pubmed/31689817
http://dx.doi.org/10.1097/MD.0000000000017731
work_keys_str_mv AT choitaeyoung koreanmedicinesforpoorovarianreserveininfertilityaprotocolforamulticenterobservationalstudy
AT junjihee koreanmedicinesforpoorovarianreserveininfertilityaprotocolforamulticenterobservationalstudy
AT leehyewon koreanmedicinesforpoorovarianreserveininfertilityaprotocolforamulticenterobservationalstudy
AT anglin koreanmedicinesforpoorovarianreserveininfertilityaprotocolforamulticenterobservationalstudy
AT kimeunseop koreanmedicinesforpoorovarianreserveininfertilityaprotocolforamulticenterobservationalstudy
AT gohoyeon koreanmedicinesforpoorovarianreserveininfertilityaprotocolforamulticenterobservationalstudy
AT yousooseong koreanmedicinesforpoorovarianreserveininfertilityaprotocolforamulticenterobservationalstudy
AT leemyeongsoo koreanmedicinesforpoorovarianreserveininfertilityaprotocolforamulticenterobservationalstudy